Scroll To Top

prep

Out former CDC vaccines head Demetre Daskalakis named chief medical officer at NYC LGBTQ+ health center

Infectious diseases specialist Dr. Demetre Daskalakis, who walked out of the CDC over Trump's health policies, will begin his new role at Callen-Lorde Community Health Center in February.

On World AIDS Day, thinking of progress and how to build on it in the face of hostility

“As long as people willing to fight, we will change the course of history,” says HRC's Matthew Rose.

CVS tells HIV activists that pharma company Gilead needs to lower price of PrEP drug if it wants it covered

A CVS executive told PrEP4All by email that the $28,000 price on a drug sold for $40 overseas was unacceptable.

It’s National PrEP Day! Learn the latest about HIV prevention

There are now more ways than ever — including long-acting injectables — to prevent the spread of HIV.

California Gov. Newsom vetoes one pro-trans bill; will he sign others?

After his podcast with the late transphobe Charlie Kirk, some are questioning Newsom's commitment to transgender equality.

Javier Muñoz and Peppermint warn Congress 'we will be back to HIV wards' if funding is cut

Javier Muñoz and Peppermint tell The Advocate about their time on Capitol Hill fighting for HIV funds.

New study ranks U.S. states with highest STI rates

Where does your state fall on the list?

Supreme Court hands RFK Jr. new power over Americans’ health, buried in PrEP case ruling

While the justices upheld the coverage requirement for insurance companies to pay for preventive care at no cost to the patient, they also gave the HHS secretary more power.

True

BREAKING: Supreme Court rules to save free access to PrEP and other preventive care

The defendants in the case previously argued that requiring insurance coverage of PrEP access was similar to supporting homosexuality.

True

FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent

Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.

Supreme Court to rule on two cases that could reshape access to health care for LGBTQ+ people

The justices are expected to issue rulings on the most controversial cases of the term imminently.

Justices Kavanaugh & Barrett signal they may uphold access to PrEP and preventive care protections

LGBTQ+ and public health advocates warn that a ruling in favor of the plaintiffs would allow insurers to begin denying or charging for services currently guaranteed to be free—like STI testing, diabetes screening, contraception, and maternal care.

What to know about the Supreme Court case that could take away your access to PrEP and other care

Here's what’s at stake in the latest Obamacare challenge that the original plaintiffs claimed encouraged people to be gay.

Lesotho's main LGBTQ+ group says it's 'not receiving grants' after Donald Trump lies

Lesotho's largest LGBTQ+ group says it has not received the millions Donald Trump claimed they have.

An out former USAID official speaks on the fatal global fallout of dissolving its LGBTQ+ programs (exclusive)

“People are begging us, ‘What do we do now? How do we keep people from being arrested, beaten, sick or worse?’ And we have no answers for them,” the former USAID official said.

Why LGBTQ+ groups are angry at RFK Jr.'s confirmation

Kennedy has denied that he ever said chemicals cause gender dysphoria or that HIV doesn't cause AIDS — but he did.

Trump administration takes away life-saving HIV prevention medications from vulnerable LGBTQ+ people worldwide

According to a State Department memo, PrEP can only be dispensed to “pregnant and breastfeeding women” through PEPFAR.

Supreme Court will decide if insurance companies must cover PrEP for HIV prevention, cancer screenings

The case stems from a Texas company that argued covering PrEP violated its religious freedoms, claiming the medication encourages “homosexual behavior.”

Gay men have been cautious about mpox. Will a second Donald Trump term set them back?

Gay men are more trusting of medicine than other groups, but the incoming Trump Administration will need more than their willingness to continue combating mpox.

Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%

Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.

Here's what Democrats promise to do for LGBTQ+ people in their 2024 platform

The DNC has released its full platform for the next four years, which features dozens of policies that would improve the lives of LGBTQ+ people.